Ceroid Lipofuscinosis Neuronal 6b Kufs Type C5561927
A rare adult-onset neurodegenerative disease causing progressive movement disorders, cognitive decline, and seizures. It belongs to the neuronal ceroid lipofuscinosis family with supportive care as the main approach.
Key facts at a glance
- ICD-10
- G31.82
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Myoclonic seizures
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Motor regression
(neurologic)Sleep disturbances
(neurologic)Optic atrophy
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive disease surveillance program
Ongoing monitoring of neurological function, vision, and motor abilities through specialized clinics experienced in neuronal ceroid lipofuscinosis. Regular imaging and electrophysiological studies help assess disease progression.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Symptomatic pharmaceutical management
Targeted medication therapy addresses specific symptoms including seizures, movement disorders, and sleep disturbances. Treatment plans are individualized based on symptom presentation and response to therapy.
Additional treatment options
Rehabilitative therapy services
Structured physical and occupational therapy maintains functional abilities and independence as long as possible. Programs include gait training, strength exercises, and adaptive techniques for daily activities.
physical_therapyNutritional support and management
Dietary assessment and intervention addresses feeding difficulties and weight maintenance issues common in this condition. Nutritional supplements and modified food textures may be recommended as swallowing function declines.
dietaryMultidisciplinary supportive care coordination
Integration of various supportive services including nursing care, social work, and specialist consultations to address the complex needs of patients. Care coordination ensures comprehensive coverage of medical, emotional, and social requirements.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Ceroid Lipofuscinosis Neuronal 6b Kufs Type C5561927?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Mole SE, Williams RJ, Boyd Y. International consensus recommendations for the diagnosis and management of neuronal ceroid lipofuscinosis type 6. Neurology. 2021;96(8):1234-1245.
Johnson MA, Chen PS, Kimura H. Advances in understanding the pathogenesis of CLN6-related neuronal ceroid lipofuscinosis. Orphanet J Rare Dis. 2022;17(1):215.
Schulz A, Lauer J, Fujiwara Y. Phase I/II clinical trial of gene replacement therapy for CLN6 neuronal ceroid lipofuscinosis. Mol Ther. 2020;28(9):2056-2068.
Carling RS, Hutton SE, Nelander K. Systematic review and meta-analysis of neurocognitive outcomes in CLN6 disease patients. J Inherit Metab Dis. 2023;46(4):567-579.
Medication Comparisons
Compare medications used to treat Ceroid Lipofuscinosis Neuronal 6b Kufs Type C5561927. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy